Gauteng exceeds first-month target in Lenacapavir HIV prevention rollout
Gauteng has surpassed its first-month target for the rollout of Lenacapavir, with eligible clients receiving the long-acting HIV prevention medication as the province expands access to HIV prevention services.
The Gauteng Department of Health has exceeded its first-month target for the rollout of the Lenacapavir (LEN) HIV prevention programme, with more than 6 000 eligible clients initiated on the medication since the phased implementation began on June 8.
Department spokesperson Steve Mabona said 6 130 eligible clients had been initiated on Lenacapavir across Gauteng, achieving 131% of the provincial monthly target of 4 672 initiations.
ALSO READ: Gauteng Health encourages use of free circumcision services
Mabona said Lenacapavir forms part of South Africa’s efforts to expand HIV prevention options and accelerate progress towards ending Aids as a public health threat by 2030.
The long-acting medication offers HIV-negative individuals at substantial risk of infection an additional prevention option that complements existing HIV prevention interventions.
The treatment is currently available at 133 clinics across the province, all of which have received sufficient stock to support service delivery.
According to Mabona, Tshwane recorded the highest number of initiations with 2 216 clients, followed by Johannesburg (1 981), Ekurhuleni (1 435), Sedibeng (377) and the West Rand (121).
ALSO READ: Gauteng Health urges residents to prevent burn injuries this winter
He said the department continued to maintain adequate stock levels, with more than 7 400 injection packs and over 7 500 oral tablet packs available at reporting facilities. A second consignment of 9 830 Lenacapavir packs was delivered to the Medical Supplies Depot on June 26 to support the programme’s continued expansion and ensure uninterrupted access.
Mabona commended healthcare workers, programme managers and facility teams across Gauteng for ensuring eligible clients could access the intervention.
He reminded the public that while Lenacapavir is an important addition to HIV prevention services, it does not replace other prevention methods.
ALSO READ: Gauteng health urges timely child vaccinations amid decline in coverage
The medication does not protect against sexually transmitted infections other than HIV or prevent unintended pregnancies.
Mabona encouraged people using Lenacapavir to continue practising safer sex by using condoms consistently and correctly, undergoing regular STI screening and accessing sexual and reproductive health services at public healthcare facilities.
